Disproportionality analysis of anaphylactic reactions after vaccination with messenger RNA coronavirus disease 2019 vaccines in the United States

Ann Allergy Asthma Immunol. 2021 Jul;127(1):139-140. doi: 10.1016/j.anai.2021.04.004. Epub 2021 Apr 8.

Authors

Guillermo Rodriguez-Nava¹, Goar Egoryan², Daniela Patricia Trelles-Garcia², Maria Adriana Yanez-Bello², Ricardo Murguia-Fuentes³

Affiliations

¹ Department of Internal Medicine, AMITA Health Saint Francis Hospital, Evanston, Illinois. Electronic address: Guillermo.RodriguezNava@amitahealth.org.
² Department of Internal Medicine, AMITA Health Saint Francis Hospital, Evanston, Illinois.
³ Department of Internal Medicine, Louisiana State University Health Sciences Center, Shreveport, Louisiana.

No abstract available

Publication types

Letter

MeSH terms

2019-nCoV Vaccine mRNA-1273
Adverse Drug Reaction Reporting Systems
Anaphylaxis / epidemiology
Anaphylaxis / etiology*
COVID-19 Vaccines / adverse effects*
Humans
United States
Vaccination / statistics & numerical data*

Substances

COVID-19 Vaccines
2019-nCoV Vaccine mRNA-1273